Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation.
Vigneswaran J, Tan YH, Murgu SD, Won BM, Patton KA, Villaflor VM, Hoffman PC, Hensing T, Hogarth DK, Malik R, MacMahon H, Mueller J, Simon CA, Vigneswaran WT, Wigfield CH, Ferguson MK, Husain AN, Vokes EE, Salgia R.
Vigneswaran J, et al. Among authors: salgia r.
Oncotarget. 2016 Apr 5;7(14):18876-86. doi: 10.18632/oncotarget.7739.
Oncotarget. 2016.
PMID: 26934441
Free PMC article.